Results 121 to 130 of about 49,423 (253)
JEADV Clinical Practice, Volume 4, Issue 1, Page 72-81, March 2025.Abstract Background Therapeutic management of hair loss is frequently complicated by a lack of high‐quality evidence and reliant on the use of unlicensed therapies. Treatment decision‐making is predominantly based on expert opinion, local availability, personal experience, and cost, which make informed choices challenging for clinicians and patients in
John Frewen +27 more
wiley +1 more source
Pili Annulati Coincident with Alopecia Areata, Autoimmune Thyroid Disease, and Primary IgA Deficiency: Case report and Considerations on the Literature [PDF]
, 2007 Pili annulati is a rare autosomal dominant hair disorder clinically characterized by a pattern of alternating bright and dark bands of the hair, the bright bands appearing dark if observed by transmitted light.
Caputo, V., Castelli, E., Fiorella, S.
core +3 more sources
Turban PUVASOL: An effective treatment in alopecia totalis
International Journal of Trichology, 2010 Alopecia areata is characterized by patchy hair loss involving the scalp, eyelashes, and beard. The disease may at times lead to complete baldness of the scalp (alopecia totalis) or of the entire body (alopecia universalis). Alopecia totalis is usually resistant to therapy.
C Shanmuga Sekar +2 more
openaire +3 more sources
Childhood alopecia areata: What treatment works best? [PDF]
, 2011 There are no validated effective treatments for alopecia areata (AA). Topical immunotherapy (squaric acid dibutylester [SADBE] and diphenylcyclopropenone [DPCP]) induces the most significant short-term hair regrowth in children with severe AA (strength ...
Haynes, James W. +2 more
core
Idiopathic Acquired Leukonychia in a 34-Year-Old Patient [PDF]
, 2009 We present a rare case of a 34-year-old patient with persistent, progressive, acquired leukonychia totalis and partialis. Idiopathic acquired leukonychia is a rare chromatic disorder of the nail not associated with other abnormalities and discernible ...
Aricò, Mario, Bongiorno, Maria Rita
core +2 more sources
Dermatologic Therapy, 2020 Dear Editor, A 61 year-old woman presented to our clinic with a 28-years history of alopecia areata (AA) with progression to alopecia totalis (AT).
G. Babino +5 more
semanticscholar +1 more source
Epidemiology of Pediatric Alopecia Areata
Pediatric Dermatology, Volume 42, Issue S1, Page 12-23, March 2025.ABSTRACT This contemporary scoping narrative review examines the epidemiology of pediatric alopecia areata (AA), focusing on incidence, prevalence, racial and ethnic differences, and comorbidities. Articles containing original epidemiology on pediatric AA published between 2013 and 2024 were identified.
Rutha Adhanom +2 more
wiley +1 more source
Frontiers in Neurology, 2017 Secondary autoimmunity is the most frequent adverse event occurring in almost every other alemtuzumab-treated multiple sclerosis patient. We report a case of a patient with relapsing-remitting multiple sclerosis who reported smooth, circular areas of ...
Julian Zimmermann +2 more
doaj +1 more source
Factors associated with the prevalence of diseases in the scalp: a prospective study in Mugdha Medical College and Hospital, Dhaka, Bangladesh [PDF]
Background: The scalp skin is distinct from other areas of the body due to its unique characteristics, including the density of hair follicles and the high rate of sebum production.
Salah Uddin, Muhammad +2 more
core +2 more sources
Immunopathogenesis of alopecia areata
Current Research in Immunology, 2021 Alopecia areata (AA) is an autoimmune disorder resulting in hair loss. It has numerous variants or patterns, including diffuse type, patchy type, AA totalis, AA universalis, and more.
Jadesola (Jadé) Temitope Olayinka +1 more
doaj